By recognising how menopause affects skin, inflammation and the microbiome balance, practitioners can better tailor treatments, strengthen patient communication and improve aesthetic outcomes, says Chiza Westcarr

As aesthetic medicine evolves, skin ageing can no longer be viewed in isolation from the internal changes that drive it. The menopause transition marks a multidimensional inflection point – hormonal, metabolic, structural and psychological. For the increasing number of midlife female patients, outcomes from injectables, energy-based devices and regenerative procedures are influenced as much by internal biochemistry as by practitioner technique. Recognising and addressing these underlying changes is becoming a new standard of care rather than simply a niche interest.

Understanding skin in midlife

Oestrogen receptors exist throughout the skin, within keratinocytes, fibroblasts, sebaceous glands and hair follicles. The progressive decline of oestrogen following menopause accelerates epidermal thinning, reduced ceramide synthesis, dermal collagen degradation, decreased glycosaminoglycan production and impaired wound healing. Histological data confirm that up to 30 percent of dermal collagen is lost in the first five years after the final menstrual period, with subsequent declines of one to two percent annually.

Beyond the skin, declining oestrogen affects where fat is stored and how the body uses energy. Menopausal women experience increased visceral adiposity, accompanied by chronic low-grade inflammation, insulin resistance and altered lipid metabolism.

These systemic dynamics have tangible consequences for recovery and tissue remodelling following procedures. Many women feel as though they’ve aged overnight; not from the passage of time, but from hormonal and metabolic change. It’s important to note that menopausal skin isn’t fragile. It’s biochemically different and our approach must evolve with it.

Sleep disruption, blood sugar instability and oxidative stress further compound collagen loss and barrier dysfunction during menopause. Elevated glucose levels promote glycation, a process where sugars bind to collagen and elastin fibres, forming advanced glycation end products (AGEs). These stiffen and weaken the skin’s support structure, reducing elasticity and impairing remodelling. Together, these factors can shorten the longevity of even technically excellent aesthetic results.

The gut-skin axis & inflammatory load

A robust body of literature now confirms bidirectional communication between the intestinal microbiome and the skin’s immune and metabolic processes. Alongside this, declining oestrogen levels reduce epidermal ceramide and lipid synthesis, weakening the barrier and diminishing hydration. Dysbiosis during midlife – exacerbated by stress, ultra-processed diets and alcohol – further amplifies inflammation through elevated circulating lipopolysaccharides and pro-inflammatory cytokines, compounding barrier vulnerability and sensitivity.

For the practitioner, this reinforces that gut health and diet are not peripheral topics but integral to achieving optimal aesthetic outcomes. Introducing simple, evidence-informed nutrition and lifestyle conversations during consultations can significantly enhance recovery and overall patient satisfaction.

Hormone therapy: understanding its role

There is solid evidence that both systemic and topical oestrogen therapies can improve skin thickness, hydration and elasticity. While these therapies can complement aesthetic treatments by improving the skin’s baseline quality, not every woman is suitable for, or interested in, menopausal hormone therapy (MHT). For practitioners, the key is to understand how hormones influence skin recovery and treatment response, so procedures can be tailored accordingly.

Building referral relationships with menopause-informed doctors and nurses ensures patients receive coordinated, individualised care.

Bringing menopause science into everyday practice

It’s one thing to understand the science of menopause, but quite another to bring that understanding into daily practice. When we connect what’s happening inside the body with how we treat the skin, our results and our patient relationships both improve.

Understanding the underlying physiology is only the first step. The real impact comes when this knowledge shapes how we consult, plan and care for patients in the treatment room. By integrating menopause-aware assessment, treatment planning and support strategies, practitioners can enhance both results and patient trust.

The following steps outline how this understanding can be applied in practice – from the way we assess and prepare the skin to how we communicate with our patients.

1. Start with a whole-patient lens

Move beyond surface assessment. Ask about cycle changes, sleep, stress and digestion – the factors that shape skin recovery, barrier strength and collagen repair. These conversations build trust and give context to every treatment planning decision.

2. Prepare, then treat

Midlife skin is thinner, drier and slower to heal. Prioritise restoring barrier function before any ablative or energy-based work. When performing collagen-stimulating treatments, introduce products for home use to prepare the skin, and allow more time between sessions to accommodate slower turnover. Reinforce recovery with adequate protein intake, sleep and stable blood sugar for better healing.

3. Nourish from within

Encourage a Mediterranean-style diet rich in protein, healthy fats and polyphenol-packed foods. These nutrients reduce inflammation, support microbiome balance and improve skin texture and elasticity – enhancing the results of your clinical work.

4. Reframe the conversation.

Today’s clients are savvy and want realistic, empowering language. Swap ‘anti-ageing’ for ‘regenerative’ or ‘ageing well’. Language such as ‘we’ll rebuild your barrier first because oestrogen changes slow repair’ educates while positioning you as an informed, caring clinician.

5. Collaborate for better outcomes

Creating connections with nutritionists, exercise professionals and menopause-trained doctors supports more holistic care and better results. Clients feel seen as whole people, not just faces, and that builds loyalty and trust.

WHEN PRACTITIONERS RECOGNISE THE CONNECTION BETWEEN HORMONES, METABOLISM AND SKIN FUNCTION, THEIR APPROACH BECOMES MORE PRECISE AND PATIENT-CENTRED.

Conclusion

Menopause is not a problem to fix. It is a natural transition that changes how the skin behaves and responds to treatment. When practitioners recognise the connection between hormones, metabolism and skin function, their approach becomes more precise and patient-centred. Bringing menopause awareness into consultations, nutrition conversations and post-treatment planning helps achieve better results and builds lasting trust with patients.

Previous articleUK strengthens pancreatitis warnings for GLP-1 medicines
Next articleEPICUTIS global sales retreat signals ANZ launch momentum